Business Novo Nordisk CEO Mike Doustdar says Ozempic maker looking for deals Finance News May 6, 2026 Novo Nordisk is looking for deals more than ever before, the CEO of the Danish drugmaker said in an interview with… Read More...
Retail How Barrière aims to disrupt the supplement industry Finance News May 6, 2026 The supplement industry has seen booming demand over the past few years as consumers increasingly focus on health and… Read More...
Politics CVS Health (CVS) earnings Q1 2026 Finance News May 6, 2026 A screen displays the logo and trading information for CVS at the New York Stock Exchange, March 24, 2026.Jeenah Moon… Read More...
Politics Novo Nordisk (NVO) Q1 2026 earnings: Wegovy sales jump Finance News May 6, 2026 People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in Copenhagen,… Read More...
Politics Pfizer (PFE) earnings Q1 2026 Finance News May 5, 2026 Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. View Press | Corbis News |… Read More...
Politics Novo Nordisk Wegovy pill beating Eli Lilly Foundayo early Finance News May 4, 2026 Still life of the new Wegovy semaglutide tablets on a white background. Its a prescription medicine used with a… Read More...
Politics Weight loss drugs pose risk to pharma, report finds Finance News May 4, 2026 Surging demand for weight loss and diabetes drugs leaves the pharmaceutical sector at risk from a "bubble effect" as… Read More...
Retail The growing market from GLP-1s Finance News May 2, 2026 When Branneisha Cooper first began taking GLP-1 injection Mounjaro in late 2022, she heard online that she could… Read More...
Politics AstraZeneca stock falls after FDA panel votes against new cancer drug Finance News May 1, 2026 Shares of AstraZeneca turned lower Friday after U.S. regulatory advisors voted against approving its experimental… Read More...
Earnings Eli Lilly (LLY) earnings Q1 2026 Finance News Apr 30, 2026 Eli Lilly on Thursday reported first-quarter earnings and revenue that blew past estimates and hiked its full-year… Read More...